Royal Healthcare Singapore Introduces NEC’s Predictive Blood Test

Royal Healthcare, a leading medical institution in Singapore’s Novena hub, has introduced NEC Corporation’s FonesVisuas Test, an innovative blood-based diagnostic tool designed to predict disease risks years in advance. The test analyzes proteins that reflect dynamic physiological changes, enabling early detection of conditions such as dementia, heart attack, lung cancer, chronic kidney disease, and prostate cancer.

Royal Healthcare Singapore

This development comes amid rising global concerns over lifestyle-related diseases and dementia, highlighted by the World Health Organization. OECD data further underscores the urgency, citing cancer and cardiovascular diseases as leading causes of mortality worldwide.

Royal Healthcare integrates the FonesVisuas Test with conventional health screenings, guiding individuals toward lifestyle improvements before illness develops. By combining personalized medical expertise with hospitality-driven care, the institution aims to enhance patient well-being and quality of life. NEC plans to expand the test’s availability across the Asia-Pacific region, reinforcing its commitment to advancing global healthcare standards.

SG Business

NTUC Now Urges Operators Not to Pass Fuel Costs to Drivers and Riders